NCT02338531View on ClinicalTrials.gov

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

December 31, 2018

Conditions
Breast Cancer
Interventions
DRUG

PF-03084014

PROCEDURE

Breast cancer surgery

Trial Locations (5)

1000

Institut Jules Bordet, Brussels

5000

CMSE, Namur

6000

Grand Hopital de Charleroi, Charleroi

94800

Institut de Cancérologie Gustave Roussy, Villejuif

750005

Institut Curie, Paris

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER